Week of December 17, 2012
  • Weak Evidence for Use of Cannabis Extract in MS
    There is no strong evidence to support the use of cannabis extract for multiple sclerosis (MS) patients, according to a study of Sativex, a drug licensed in several other countries and pending FDA approval in the U.S. Read more….
  • JOBS: No Holiday for Job Openings

    Keep your job search going during this busy season with PharmJobs. Just click on a link to search for positions by company, city or state, and then view job details. Find a job….

  • Study: Generics Often Have Incorrect Safety Labeling

    A new study has found that more than two-thirds of generic drugs have safety-warning labels that differ from the equivalent brand-name drug, despite FDA regulations requiring identical warnings. Learn more….

  • Patient Teaching Aid: Influenza

    Find free teaching aids in the Resources section of PharmQD. View, download and print these helpful guides to discuss with patients on topics of concern to them. Featured this month: Influenza.

  • FDA Expands Zytiga’s Use for Prostate Cancer

    The FDA expanded the approved use of Zytiga (abiraterone acetate) to treat men with late-stage (metastatic) castration-resistant prostate cancer prior to receiving chemotherapy. Read more….

www.PharmQD.com
The place for members to create & maintain connections with
pharmacy peers and prospective employers.




Not a member? Join PharmQD!